Menu
We are delighted to announce the successful completion of Phase II, where we collaborated with three exceptional suppliers, each contributing their expertise and cutting-edge technologies to our mission. The dedication and quality of their solutions met our expectations, making the evaluation process truly challenging. However, as we proceed to Phase III, we must be mindful of budget constraints, which led us to select two suppliers to continue this remarkable journey. Rest assured, though only two suppliers move forward, their collective prowess promises to drive us closer to the provision of an efficient, integrated, cost-effective way of better managing care for people with chronic heart failure (CHF), and preparing the pilots that are about to start in December.
Our two suppliers for Phase III are:
Using a patient-centered approach, PULSE aims to build a digital ecosystem that allows patients to self-manage and for care providers to provider a better service through a constant stream of information between both actors. By building a system that allows for seamless interaction between electronic health record systems, measuring devices and software, PULSE would create multidimensional data that can assist care providers with delivery of care, while teaching patients how to effectively manage the disease with interactive learning tools, coaching support, gamification and exergaming.
The PULSE consortium is led by Hytton Technologies.
The IncareNova solution is being developed by Innova IT Solutions to provide an interoperable application that helps patients manage their CHF within the context of their environment and any other health issues. As well as monitoring patients themselves, the InCareNova solution would also include environmental data like air quality and humidity, allowing its AI driven system to better advise patients on how to manage their condition day to day. The system is also being designed with a modular structure, so it can be better integrated into the care process of other chronic diseases which a patient may also be managing.
The CareCardia solution seeks to address the ‘Homer’s Odyssey’ that CHF patients face in managing their condition due to the pitfalls and gaps in communication while dealing with multiple healthcare actors. CareCardia would integrate state-of-the-art, clinical evidence-based technologies into a single digital platform where CHF patients can manager their care and interact with their care providers.
Using remote health monitoring, AI-data processing, and an interoperable system that can share information and break down silos of communication, CareCardia would create a holistic platform for patients and their care providers.
The CareCardia consortium is led by Gnomon Informatics SA.
CardioCare is led by Gesan SRL, a software house with vast experience in the healthcare ICT sector. The CardioCare platform aims to manage CHF through a platform that allows an easy exchange of data between patient and clinician, backed by AI analytics. CardioCare would allow patients to use portable medical devices to track vital signs and provide smart assessments to help in the management of their care, as well as offering a virtual assistant, gamification and other learning tools. Interoperable with existing ICT systems, CardioCare would also make management for clinicians more efficient and effective.
CardioCare also focuses on using mindfulness and education to empower patients to better manage their own care and achieve better health outcomes.
The goal of the Inno4HF project is to create a holistic technological solution for heart failure management, providing a digital platform that can connect across a range of devices and systems, backed by advanced data analytics. Using disruptive technology from the consortium partners, Inno4HF would revolutionise heart failure monitoring and would make diagnostic and treatments decisions more accurate by creating an evidence-based database for healthcare providers, leading to better clinical outcomes for patients.
The Inno4HF consortium is lead by Izertis.
The CORRAL project aims to create a digital solution for the continuous management and integrated care of chronic heart failure, covering early detection and secondary prevention, care and follow-up, and for supporting people to live with CHF at home. The platform would allow for monitoring of environmental, physical and psychological patient-related variables, and continuous analysis of recorded data and care team inputs by an artificial intelligence system to support decision making by care teams and the provision of personalized support and education interventions allowing patients to self-manage CHF.
The CORRAL consortium is lead by CERTH.
